Shuuji Sumino

Efficacy and safety of leuprorelin acetate 6-month depot, TAP-144-SR (6M), in combination with tamoxifen in postoperative, premenopausal patients with hormone receptor-positive breast cancer: a phase III, randomized, open-label, parallel-group comparative study

Junichi Kurebayashi, Tatsuya Toyama, Shuuji Sumino et al. · Breast Cancer · 2016 · 20 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Phase 2 single-arm study on the efficacy and safety of niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer

Aikou Okamoto, Eiji Kondo, Toshiaki Nakamura et al. · Journal of Gynecologic Oncology · 2020 · 14 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +16

Randomized, double‐blind, phase <scp>III</scp> study to evaluate the efficacy and safety of once‐daily treatment with alogliptin and metformin hydrochloride in Japanese patients with type 2 diabetes

Kohei Kaku, Shuuji Sumino, Masafumi Katou et al. · Diabetes Obesity and Metabolism · 2016 · 13 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Phase 2 single-arm study on the safety of maintenance niraparib in Japanese patients with platinum-sensitive relapsed ovarian cancer

Kazuhiro Takehara, Takashi Matsumoto, Junzo Hamanishi et al. · Journal of Gynecologic Oncology · 2021 · 13 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

The safety, tolerability and pharmacokinetics of niraparib in Japanese patients with solid tumours: results of a phase I dose-escalation study

Kan Yonemori, Toshio Shimizu, Shunsuke Kondo et al. · Japanese Journal of Clinical Oncology · 2021 · 10 citations · Full text

Pharmacy, Oncology, Pharmacology +15